Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Gynecology

Free Subscription Articles published in Lancet Retrieve available abstracts of 79 articles: HTML format Text format

Single Articles

May 2019
1. JAFFE S
   Legal battles over abortion heat up in the USA.
   Lancet. 2019;393:1923-1924.
   PubMed     Text format    
   
   
   
2. LI A
   Northern Ireland deadlock impedes abortion rights progress.
   Lancet. 2019;393:1794.
   PubMed     Text format    
   
   
   
3. BUJOLD E, Chaillet N, Kingdom J
   Placental growth factor testing for suspected pre-eclampsia.
   Lancet. 2019;393:1775-1776.
   PubMed     Text format    
   
   
   April 2019
4. THE LANCET
   Progress on investigating stillbirths.
   Lancet. 2019;393:1386.
   PubMed     Text format    
   
   
   
5. DUHIG KE, Myers J, Seed PT, Sparkes J, et al
   Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial.
   Lancet. 2019 Apr 1. pii: S0140-6736(18)33212.
   PubMed     Text format     Abstract available
   
   
   March 2019
6. THE LANCET
   Gestational diabetes in England: cause for concern.
   Lancet. 2019;393:1262.
   PubMed     Text format    
   
   
   
7. WEI D, Liu JY, Sun Y, Shi Y, et al
   Frozen versus fresh single blastocyst transfer in ovulatory women: a multicentre, randomised controlled trial.
   Lancet. 2019;393:1310-1318.
   PubMed     Text format     Abstract available
   
   
   
8. LHEUREUX S, Gourley C, Vergote I, Oza AM, et al
   Epithelial ovarian cancer.
   Lancet. 2019;393:1240-1253.
   PubMed     Text format     Abstract available
   
   
   
9. WATSON K
   Abortion as a moral good.
   Lancet. 2019;393:1196-1197.
   PubMed     Text format    
   
   
   
10. LAUFER MK
    Beyond birthweight: benefits and risks of preventing malaria in pregnancy.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32615.
    PubMed     Text format    
    
    
    
11. KAJUBI R, Ochieng T, Kakuru A, Jagannathan P, et al
    Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
    Lancet. 2019 Mar 22. pii: S0140-6736(18)32224.
    PubMed     Text format     Abstract available
    
    
    
12. ZHAO F, Qiao Y
    Cervical cancer prevention in China: a key to cancer control.
    Lancet. 2019;393:969-970.
    PubMed     Text format    
    
    
    February 2019
13. KLEBANOFF MA
    Interpregnancy interval after stillbirth: modifiable, but does it matter?
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32430.
    PubMed     Text format    
    
    
    
14. REGAN AK, Gissler M, Magnus MC, Haberg SE, et al
    Association between interpregnancy interval and adverse birth outcomes in women with a previous stillbirth: an international cohort study.
    Lancet. 2019 Feb 28. pii: S0140-6736(18)32266.
    PubMed     Text format     Abstract available
    
    
    
15. KIOKO PM, Meana PR
    Abortion in Argentina.
    Lancet. 2019;393:745.
    PubMed     Text format    
    
    
    
16. GARCIA G
    Abortion in Argentina.
    Lancet. 2019;393:744.
    PubMed     Text format    
    
    
    
17. UZOIGWE CE
    Abortion in Argentina.
    Lancet. 2019;393:744-745.
    PubMed     Text format    
    
    
    
18. OVADIA C, Seed PT, Sklavounos A, Geenes V, et al
    Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)31877.
    PubMed     Text format     Abstract available
    
    
    
19. PALMER KR, Xiaohua L, Mol BW
    Management of intrahepatic cholestasis in pregnancy.
    Lancet. 2019 Feb 14. pii: S0140-6736(18)32323.
    PubMed     Text format    
    
    
    
20. REPPING S
    Evidence-based medicine and infertility treatment.
    Lancet. 2019;393:380-382.
    PubMed     Text format    
    
    
    
21. MILLER D, Pavitt S, Sharma V, Forbes G, et al
    Physiological, hyaluronan-selected intracytoplasmic sperm injection for infertility treatment (HABSelect): a parallel, two-group, randomised trial.
    Lancet. 2019;393:416-422.
    PubMed     Text format     Abstract available
    
    
    January 2019
22. HOFMEYR GJ, Betran AP, Singata-Madliki M, Cormick G, et al
    Prepregnancy and early pregnancy calcium supplementation among women at high risk of pre-eclampsia: a multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet. 2019;393:330-339.
    PubMed     Text format     Abstract available
    
    
    
23. BUJOLD E, Hyett J
    Calcium supplementation for prevention of pre-eclampsia.
    Lancet. 2019;393:298-300.
    PubMed     Text format    
    
    
    
24. COHEN PA, Jhingran A, Oaknin A, Denny L, et al
    Cervical cancer.
    Lancet. 2019;393:169-182.
    PubMed     Text format     Abstract available
    
    
    
25. THE LANCET
    Cervical cancer: unequal progress.
    Lancet. 2019;393:104.
    PubMed     Text format    
    
    
    December 2018
26. BERNITZ S, Dalbye R, Zhang J, Eggebo TM, et al
    The frequency of intrapartum caesarean section use with the WHO partograph versus Zhang's guideline in the Labour Progression Study (LaPS): a multicentre, cluster-randomised controlled trial.
    Lancet. 2018 Dec 20. pii: S0140-6736(18)31991.
    PubMed     Text format     Abstract available
    
    
    
27. DIAZ-GARCIA C, Pellicer A
    Uterus transplantation from a deceased donor.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)32106.
    PubMed     Text format    
    
    
    
28. EJZENBERG D, Andraus W, Baratelli Carelli Mendes LR, Ducatti L, et al
    Livebirth after uterus transplantation from a deceased donor in a recipient with uterine infertility.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)31766.
    PubMed     Text format     Abstract available
    
    
    November 2018
29. THE LANCET
    Addressing preventable stillbirth and brain injury.
    Lancet. 2018;392:2238.
    PubMed     Text format    
    
    
    October 2018
30. FARQUHAR C
    Unexplained infertility - Authors' reply.
    Lancet. 2018;392:1517.
    PubMed     Text format    
    
    
    
31. GLEICHER N, Kuhnir VA, Barad DH
    Unexplained infertility.
    Lancet. 2018;392:1516-1517.
    PubMed     Text format    
    
    
    
32. HOCKING JS, Temple-Smith M, Guy R, Donovan B, et al
    Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial.
    Lancet. 2018;392:1413-1422.
    PubMed     Text format     Abstract available
    
    
    
33. ADAMSON PC, Klausner JD
    No benefit of chlamydia screening in primary care?
    Lancet. 2018;392:1381-1383.
    PubMed     Text format    
    
    
    
34. SUBTIL D, Brabant G, Tilloy E, Devos P, et al
    Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)31617.
    PubMed     Text format     Abstract available
    
    
    
35. KLEBANOFF MA, Brotman RM
    Treatment of bacterial vaginosis to prevent preterm birth.
    Lancet. 2018 Oct 12. pii: S0140-6736(18)32115.
    PubMed     Text format    
    
    
    September 2018
36. TEMMERMAN M, Lawn JE
    Stillbirths count, but it is now time to count them all.
    Lancet. 2018 Sep 27. pii: S0140-6736(18)32342.
    PubMed     Text format    
    
    
    
37. SMITH LK, Hindori-Mohangoo AD, Delnord M, Durox M, et al
    Quantifying the burden of stillbirths before 28 weeks of completed gestational age in high-income countries: a population-based study of 19 European countries.
    Lancet. 2018 Sep 27. pii: S0140-6736(18)31651.
    PubMed     Text format     Abstract available
    
    
    August 2018
38. GRESSLER LE, Titus-Glover D, Shaya FT
    Treatment modalities for pregnant women with opioid use disorder.
    Lancet. 2018;392:551.
    PubMed     Text format    
    
    
    
39. SEN A, Nashef L
    New regulations to cut valproate-exposed pregnancies.
    Lancet. 2018;392:458-460.
    PubMed     Text format    
    
    
    July 2018
40. GHOSN J, Taiwo B, Seedat S, Autran B, et al
    HIV.
    Lancet. 2018 Jul 23. pii: S0140-6736(18)31311.
    PubMed     Text format     Abstract available
    
    
    
41. THE LANCET
    Cervical cancer prevention in Thailand-a model of success.
    Lancet. 2018;392:2.
    PubMed     Text format    
    
    
    June 2018
42. LI A
    From Ireland to Northern Ireland: campaigns for abortion law.
    Lancet. 2018;391:2403-2404.
    PubMed     Text format    
    
    
    
43. BOOTH A
    Argentina votes on bill to legalise abortion up to 14 weeks.
    Lancet. 2018;391:e21-e22.
    PubMed     Text format    
    
    
    
44. THE LANCET
    Dolutegravir for HIV: a lesson in pregnancy safety research.
    Lancet. 2018;391:2296.
    PubMed     Text format    
    
    
    May 2018
45. HALLGARTEN L
    Abortion narratives: moving from statistics to stories.
    Lancet. 2018 May 8. pii: S0140-6736(18)31036.
    PubMed     Text format    
    
    
    
46. SPERBER A
    El Salvador's total ban on abortion risks women's health.
    Lancet. 2018;391:1758-1759.
    PubMed     Text format    
    
    
    April 2018
47. BARNETT R
    Syphilis.
    Lancet. 2018;391:1471.
    PubMed     Text format    
    
    
    March 2018
48. THE LANCET
    Diagnosis of heavy menstrual bleeding: a change in direction.
    Lancet. 2018;391:1122.
    PubMed     Text format    
    
    
    
49. THE LANCET
    Abortion: access and safety worldwide.
    Lancet. 2018;391:1121.
    PubMed     Text format    
    
    
    
50. WATTS G
    New York Challenge sets high bar for HPV vaccination.
    Lancet. 2018;391:1137.
    PubMed     Text format    
    
    
    February 2018
51. MUSALLAM R, Salem N, Al Halol R, Al Deeb H, et al
    Management of pregnancy loss in the first trimester: a retrospective audit.
    Lancet. 2018;391 Suppl 2:S34.
    PubMed     Text format     Abstract available
    
    
    
52. HABABEH M, Zeidan W, El-Kader MA, Thaher AA, et al
    Contraceptive use by Palestine refugee mothers of young children attending UNRWA clinics: a cross-sectional follow-up study.
    Lancet. 2018;391 Suppl 2:S26.
    PubMed     Text format     Abstract available
    
    
    
53. KATEEB E, Momany E
    Factors related to high dental caries experience in Palestinian pregnant women in the Jerusalem governorate: a cross-sectional study.
    Lancet. 2018;391 Suppl 2:S11.
    PubMed     Text format     Abstract available
    
    
    
54. LARSON HJ
    A global girl gang.
    Lancet. 2018;391:527-528.
    PubMed     Text format    
    
    
    
55. DEVI S
    FGM in Sierra Leone.
    Lancet. 2018;391:415.
    PubMed     Text format    
    
    
    December 2017
56. WEISS NS, Nahuis MJ, Bordewijk E, Oosterhuis JE, et al
    Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomised, two-by-two factorial trial.
    Lancet. 2017 Dec 19. pii: S0140-6736(17)33308.
    PubMed     Text format     Abstract available
    
    
    
57. CAHILL N, Sonneveldt E, Stover J, Weinberger M, et al
    Modern contraceptive use, unmet need, and demand satisfied among women of reproductive age who are married or in a union in the focus countries of the Family Planning 2020 initiative: a systematic analysis using the Family Planning Estimation Tool.
    Lancet. 2017 Dec 4. pii: S0140-6736(17)33104.
    PubMed     Text format     Abstract available
    
    
    
58. KVASKOFF M, Horne AW, Missmer SA
    Informing women with endometriosis about ovarian cancer risk.
    Lancet. 2017;390:2433-2434.
    PubMed     Text format    
    
    
    November 2017
59. GHORANI E, Kaur B, Fisher RA, Short D, et al
    Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia.
    Lancet. 2017;390:2343-2345.
    PubMed     Text format    
    
    
    
60. NANDI A, El-Toukhy T
    Stimulated intrauterine insemination for unexplained subfertility.
    Lancet. 2017 Nov 23. pii: S0140-6736(17)33038.
    PubMed     Text format    
    
    
    
61. FARQUHAR CM, Liu E, Armstrong S, Arroll N, et al
    Intrauterine insemination with ovarian stimulation versus expectant management for unexplained infertility (TUI): a pragmatic, open-label, randomised, controlled, two-centre trial.
    Lancet. 2017 Nov 23. pii: S0140-6736(17)32406.
    PubMed     Text format     Abstract available
    
    
    
62. KENDLER DL, Marin F, Zerbini CAF, Russo LA, et al
    Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial.
    Lancet. 2017 Nov 9. pii: S0140-6736(17)32137.
    PubMed     Text format     Abstract available
    
    
    
63. MABEY D, Marks M, Peeling R, Lawn J, et al
    Stillbirth caused by syphilis remains a major global health problem.
    Lancet. 2017;390:2036.
    PubMed     Text format    
    
    
    
64. HEININGER U
    Syphilis in children.
    Lancet. 2017;390:2035-2036.
    PubMed     Text format    
    
    
    October 2017
65. REGAN L, Glasier A
    The British 1967 Abortion Act-still fit for purpose?
    Lancet. 2017;390:1936-1937.
    PubMed     Text format    
    
    
    
66. YIN Y
    HPV vaccination in China needs to be more cost-effective.
    Lancet. 2017;390:1735-1736.
    PubMed     Text format    
    
    
    September 2017
67. CASASSUS B
    Contraception implant removed from global market.
    Lancet. 2017;390:1576.
    PubMed     Text format    
    
    
    
68. GEMZELL-DANIELSSON K, Cleeve A
    Estimating abortion safety: advancements and challenges.
    Lancet. 2017 Sep 27. pii: S0140-6736(17)32135.
    PubMed     Text format    
    
    
    
69. GANATRA B, Gerdts C, Rossier C, Johnson BR Jr, et al
    Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model.
    Lancet. 2017 Sep 27. pii: S0140-6736(17)31794.
    PubMed     Text format     Abstract available
    
    
    
70. GARG SK, Polsky S
    Continuous glucose monitoring in pregnant women with type 1 diabetes.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32449.
    PubMed     Text format    
    
    
    
71. FEIG DS, Donovan LE, Corcoy R, Murphy KE, et al
    Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Lancet. 2017 Sep 14. pii: S0140-6736(17)32400.
    PubMed     Text format     Abstract available
    
    
    
72. DIZON DS
    PARP inhibitors for targeted treatment in ovarian cancer.
    Lancet. 2017 Sep 12. pii: S0140-6736(17)32418.
    PubMed     Text format    
    
    
    
73. COLEMAN RL, Oza AM, Lorusso D, Aghajanian C, et al
    Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2017 Sep 12. pii: S0140-6736(17)32440.
    PubMed     Text format     Abstract available
    
    
    
74. DENNY L
    Nine-valent human papillomavirus vaccine: great science, but will it save lives?
    Lancet. 2017 Sep 5. pii: S0140-6736(17)32144.
    PubMed     Text format    
    
    
    
75. HUH WK, Joura EA, Giuliano AR, Iversen OE, et al
    Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
    Lancet. 2017 Sep 5. pii: S0140-6736(17)31821.
    PubMed     Text format     Abstract available
    
    
    July 2017
76. BANERJEE S
    Bevacizumab in cervical cancer: a step forward for survival.
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31965.
    PubMed     Text format    
    
    
    
77. TEWARI KS, Sill MW, Penson RT, Huang H, et al
    Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240).
    Lancet. 2017 Jul 27. pii: S0140-6736(17)31607.
    PubMed     Text format     Abstract available
    
    
    April 2017
78. THE LANCET
    Syphilis: an ancient disease in a modern era.
    Lancet. 2017;389:1492.
    PubMed     Text format    
    
    
    December 2016
79. HOOK EW RD
    Syphilis.
    Lancet. 2016 Dec 16. pii: S0140-6736(16)32411.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: